INTERNATIONAL PATENT: ALTEOGEN INC., (주)알테오젠 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS INJECTION, COMPRISING GROWTH HORMONE RECEPTOR ANTAGONIST AND LONG-ACTING CARRIER"

GENEVA, Dec. 10 -- ALTEOGEN INC. (62, Yuseong-daero 1628beon-gil,Yuseong-gu,Daejeon 34054), (주)알테오젠 (대전광역시유성구유성대로 1628번길 62) filed a patent application (PCT/KR2025/007364) for "PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS INJECTION, COMPRISING GROWTH HORMONE RECEPTOR ANTAGONIST AND LONG-ACTING CARRIER" on May 29, 2025. With publication no. WO/2025/249934, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

In...